MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 10.03.2026
Exagen DSO 2011-2026 | XGN
DSO Jährlich Exagen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.2 | 47.2 | 43.9 | 63 | 70.1 | 77.5 | 51.6 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 77.5 | 43.9 | 57.8 |
DSO Vierteljährlich Exagen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.1 | 76.9 | 66.4 | - | 76.9 | 68.5 | 55.2 | - | 113 | 82.4 | 62.5 | - | 60 | 118 | 90.3 | - | 67 | 60.7 | 73.8 | - | - | 90.9 | 69.6 | - | 50 | 49.8 | 57.5 | - | 33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 118 | 33 | 70.9 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
49.2 | $ 25.83 | - | $ 717 M |  USA |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
87 | $ 66.34 | - | $ 25.9 B | USA |
 |
Bioventus
BVS
|
82.1 | $ 8.87 | - | $ 591 M | USA |
 |
Guardant Health
GH
|
46.1 | $ 87.18 | 1.98 % | $ 10.9 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
65 | $ 151.97 | - | $ 7.53 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 17.32 | - | $ 923 M | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 97.61 | - | $ 8.05 B |  Irlanda |
 |
IQVIA Holdings
IQV
|
73.9 | $ 164.89 | - | $ 28.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
30.8 | $ 103.85 | - | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 14.95 | - | $ 452 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 17.29 | - | $ 2.24 B | USA |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.84 | - | $ 92.2 K | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 9.11 | - | $ 1.98 B | USA |
 |
Danaher Corporation
DHR
|
55.3 | $ 191.39 | - | $ 136 B | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Pacific Biosciences of California
PACB
|
71.8 | $ 1.36 | - | $ 408 M | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 119.28 | - | $ 19 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 198.94 | - | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
63.8 | $ 111.83 | - | $ 34 B | USA |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.11 | - | $ 1.41 M | USA |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 8.42 | -6.44 % | $ 239 M |  Israel |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 78.5 | - | $ 5.3 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
101 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 453.64 | - | $ 13.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 45.01 | - | $ 2.69 B | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 198.71 | - | $ 24.7 B |  Schweiz |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 17.4 | - | $ 389 M | USA |
 |
NeoGenomics
NEO
|
77.7 | $ 8.24 | - | $ 1.06 B | USA |
 |
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
81.5 | $ 197.68 | - | $ 19.5 B | USA |